View Future GrowthMcKesson 과거 순이익 실적과거 기준 점검 5/6McKesson은 연평균 44.3%의 비율로 수입이 증가해 온 반면, Healthcare 산업은 연평균 9.3%의 비율로 증가했습니다. 매출은 연평균 10.7%의 비율로 증가했습니다.핵심 정보44.32%순이익 성장률45.18%주당순이익(EPS) 성장률Healthcare 산업 성장률16.71%매출 성장률10.74%자기자본이익률n/a순이익률1.18%다음 순이익 업데이트05 Aug 2026최근 과거 실적 업데이트공고 • Jun 25McKesson Corporation to Report Q1, 2027 Results on Aug 05, 2026McKesson Corporation announced that they will report Q1, 2027 results on Aug 05, 2026Reported Earnings • May 08Full year 2026 earnings released: EPS: US$38.53 (vs US$25.86 in FY 2025)Full year 2026 results: EPS: US$38.53 (up from US$25.86 in FY 2025). Revenue: US$403.4b (up 12% from FY 2025). Net income: US$4.76b (up 45% from FY 2025). Profit margin: 1.2% (up from 0.9% in FY 2025). The increase in margin was driven by higher revenue. Revenue is forecast to grow 6.7% p.a. on average during the next 3 years, compared to a 5.1% growth forecast for the Healthcare industry in Europe.공고 • Mar 06McKesson Corporation to Report Q4, 2026 Results on May 07, 2026McKesson Corporation announced that they will report Q4, 2026 results After-Market on May 07, 2026Reported Earnings • Feb 05Third quarter 2026 earnings released: EPS: US$9.63 (vs US$6.98 in 3Q 2025)Third quarter 2026 results: EPS: US$9.63 (up from US$6.98 in 3Q 2025). Revenue: US$106.2b (up 11% from 3Q 2025). Net income: US$1.19b (up 35% from 3Q 2025). Profit margin: 1.1% (up from 0.9% in 3Q 2025). The increase in margin was driven by higher revenue. Revenue is forecast to grow 7.4% p.a. on average during the next 3 years, compared to a 5.2% growth forecast for the Healthcare industry in Europe.공고 • Dec 22McKesson Corporation to Report Q3, 2026 Results on Feb 04, 2026McKesson Corporation announced that they will report Q3, 2026 results After-Market on Feb 04, 2026Reported Earnings • Nov 06Second quarter 2026 earnings released: EPS: US$8.95 (vs US$1.87 in 2Q 2025)Second quarter 2026 results: EPS: US$8.95 (up from US$1.87 in 2Q 2025). Revenue: US$103.2b (up 10% from 2Q 2025). Net income: US$1.11b (up 361% from 2Q 2025). Profit margin: 1.1% (up from 0.3% in 2Q 2025). The increase in margin was driven by higher revenue. Revenue is forecast to grow 7.7% p.a. on average during the next 3 years, compared to a 5.1% growth forecast for the Healthcare industry in Europe.모든 업데이트 보기Recent updates공고 • Jul 23McKesson Corporation announces Quarterly dividend, payable on October 01, 2026McKesson Corporation announced Quarterly dividend of USD 0.9400 per share payable on October 01, 2026, ex-date on September 01, 2026 and record date on September 01, 2026.공고 • Jul 01McKesson Corporation Announces Management Changes, Effective August 1, 2026McKesson Corporation announced that on June 29, 2026, Thomas L. Rodgers, the company's Executive Vice President, Chief Strategy and Business Development Officer and a named executive officer, gave notice of his intention to retire from that role. His last day of employment will be August 1, 2026. To support an orderly transition, the company appointed Ramesh Srinivasan as Executive Vice President, Chief Strategy Officer, effective on August 1, 2026.공고 • Jun 25McKesson Corporation to Report Q1, 2027 Results on Aug 05, 2026McKesson Corporation announced that they will report Q1, 2027 results on Aug 05, 2026공고 • Jun 15McKesson Corporation, Annual General Meeting, Jul 22, 2026McKesson Corporation, Annual General Meeting, Jul 22, 2026.Upcoming Dividend • May 23Upcoming dividend of US$0.82 per shareEligible shareholders must have bought the stock before 29 May 2026. Payment date: 01 July 2026. Payout ratio is a comfortable 8.2% and this is well supported by cash flows. Trailing yield: 0.4%. Lower than top quartile of Italian dividend payers (4.5%). Lower than average of industry peers (2.6%).Reported Earnings • May 08Full year 2026 earnings released: EPS: US$38.53 (vs US$25.86 in FY 2025)Full year 2026 results: EPS: US$38.53 (up from US$25.86 in FY 2025). Revenue: US$403.4b (up 12% from FY 2025). Net income: US$4.76b (up 45% from FY 2025). Profit margin: 1.2% (up from 0.9% in FY 2025). The increase in margin was driven by higher revenue. Revenue is forecast to grow 6.7% p.a. on average during the next 3 years, compared to a 5.1% growth forecast for the Healthcare industry in Europe.Declared Dividend • May 04Dividend of US$0.82 announcedShareholders will receive a dividend of US$0.82. Ex-date: 29th May 2026 Payment date: 1st July 2026 Dividend yield will be 0.3%, which is lower than the industry average of 1.7%. Payout Ratios Payout ratio: 9%. Cash payout ratio: 4%.공고 • Apr 23McKesson Corporation Declares Regular Dividend, Payable on July 1, 2026The Board of Directors of McKesson Corporation declared a regular dividend of 82 cents per share of common stock. The dividend will be payable on July 1, 2026, to shareholders of record on June 1, 2026.공고 • Apr 22Apollo Global Management, Inc. (NYSE:APO) entered into a definitive agreement to acquire 13% stake in McKesson Medical-Surgical Inc. from McKesson Corporation (NYSE:MCK) for $1.3 billion.Apollo Global Management, Inc. (NYSE:APO) entered into a definitive agreement to acquire 13% stake in McKesson Medical-Surgical Inc. from McKesson Corporation (NYSE:MCK) for $1.3 billion on April 20, 2026. The consideration consists of convertible preferred equity of Apollo Global Management, Inc. having a value of $1.25 billion to be issued for common equity of McKesson Medical-Surgical Inc. Following the acquisition, McKesson will retain operating control and majority ownership of MMS and consolidate the results for financial reporting. The transaction is subject to regulatory approvals and customary closing conditions. Tracey Zaccone, Michael Anastasio, Salvatore Vanchieri, and Julian Azran of Latham & Watkins LLP acted as legal advisor for Apollo Global Management, Inc. Alan F. Denenberg and Michael Diz, Jason Bassetti, Patrick E. Sigmon, Liang Zhang, Adam Kaminsky, Frank Azzopardi, and Suzanne Munck af Rosenschold of Davis Polk & Wardwell LLP acted as legal advisor for McKesson Corporation.New Risk • Mar 27New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Italian stocks, typically moving 7.6% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (7.6% average weekly change). Minor Risk Negative equity (-US$99m).공고 • Mar 06McKesson Corporation to Report Q4, 2026 Results on May 07, 2026McKesson Corporation announced that they will report Q4, 2026 results After-Market on May 07, 2026공고 • Mar 05+ 1 more updateMckesson Corporation Announces CFO TransitionMcKesson Corporation announced Britt Vitalone, Executive Vice President and Chief Financial Officer (CFO), has elected to retire after a successful and distinguished 20-year career with the company, including more than eight years as CFO. Looking ahead, Kenny Cheung will join McKesson as CFO, effective May 29, 2026. Vitalone’s care and commitment to McKesson continues. While he will retire as the CFO, he will continue his work with McKesson, thereafter, as a strategic advisor to support a smooth transition and the planned separation of McKesson’s Medical Surgical Solutions. Cheung joins McKesson from Sysco, where he served as Executive Vice President and Chief Financial Officer, overseeing global financial planning and analysis, accounting, audit, tax, and corporate finance.Upcoming Dividend • Feb 20Upcoming dividend of US$0.82 per shareEligible shareholders must have bought the stock before 27 February 2026. Payment date: 01 April 2026. Payout ratio is a comfortable 8.8% and this is well supported by cash flows. Trailing yield: 0.4%. Lower than top quartile of Italian dividend payers (4.6%). Lower than average of industry peers (2.2%).New Risk • Feb 10New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Italian stocks, typically moving 5.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Negative equity (-US$99m). Share price has been volatile over the past 3 months (5.2% average weekly change).Reported Earnings • Feb 05Third quarter 2026 earnings released: EPS: US$9.63 (vs US$6.98 in 3Q 2025)Third quarter 2026 results: EPS: US$9.63 (up from US$6.98 in 3Q 2025). Revenue: US$106.2b (up 11% from 3Q 2025). Net income: US$1.19b (up 35% from 3Q 2025). Profit margin: 1.1% (up from 0.9% in 3Q 2025). The increase in margin was driven by higher revenue. Revenue is forecast to grow 7.4% p.a. on average during the next 3 years, compared to a 5.2% growth forecast for the Healthcare industry in Europe.Declared Dividend • Feb 01Dividend of US$0.82 announcedShareholders will receive a dividend of US$0.82. Ex-date: 27th February 2026 Payment date: 1st April 2026 Dividend yield will be 0.3%, which is lower than the industry average of 1.7%. Payout Ratios Payout ratio: 9%. Cash payout ratio: 7%.공고 • Jan 28Mckesson Corporation Declares Dividend, Payable on April 1, 2026McKesson Corporation declares regular dividend of 82 cents per share of common stock. The dividend will be payable on Aril 1, 2026 to shareholders of record on March 2, 2026.공고 • Dec 22McKesson Corporation to Report Q3, 2026 Results on Feb 04, 2026McKesson Corporation announced that they will report Q3, 2026 results After-Market on Feb 04, 2026Upcoming Dividend • Nov 21Upcoming dividend of US$0.82 per shareEligible shareholders must have bought the stock before 28 November 2025. Payment date: 02 January 2026. Payout ratio is a comfortable 9.1% and this is well supported by cash flows. Trailing yield: 0.4%. Lower than top quartile of Italian dividend payers (4.9%). Lower than average of industry peers (2.4%).Reported Earnings • Nov 06Second quarter 2026 earnings released: EPS: US$8.95 (vs US$1.87 in 2Q 2025)Second quarter 2026 results: EPS: US$8.95 (up from US$1.87 in 2Q 2025). Revenue: US$103.2b (up 10% from 2Q 2025). Net income: US$1.11b (up 361% from 2Q 2025). Profit margin: 1.1% (up from 0.3% in 2Q 2025). The increase in margin was driven by higher revenue. Revenue is forecast to grow 7.7% p.a. on average during the next 3 years, compared to a 5.1% growth forecast for the Healthcare industry in Europe.Declared Dividend • Nov 03Dividend of US$0.82 announcedShareholders will receive a dividend of US$0.82. Ex-date: 28th November 2025 Payment date: 2nd January 2026 Dividend yield will be 0.3%, which is lower than the industry average of 1.7%. Payout Ratios Payout ratio: 11%. Cash payout ratio: 7%.공고 • Oct 30McKesson Corporation Declares Quarterly Dividend on Common Stock, Payable on January 2, 2026The Board of Directors of McKesson Corporation declared a regular dividend of 82 cents per share of common stock. The dividend will be payable on January 2, 2026 to shareholders of record on December 1, 2025.공고 • Sep 23McKesson Corporation to Report Q2, 2026 Results on Nov 05, 2025McKesson Corporation announced that they will report Q2, 2026 results at 4:00 PM, US Eastern Standard Time on Nov 05, 2025Reported Earnings • Aug 07First quarter 2026 earnings released: EPS: US$6.28 (vs US$7.05 in 1Q 2025)First quarter 2026 results: EPS: US$6.28 (down from US$7.05 in 1Q 2025). Revenue: US$97.8b (up 23% from 1Q 2025). Net income: US$784.0m (down 14% from 1Q 2025). Profit margin: 0.8% (down from 1.2% in 1Q 2025). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 7.5% p.a. on average during the next 3 years, compared to a 5.0% growth forecast for the Healthcare industry in Europe.공고 • Jul 30Mckesson Corporation Declares Regular Dividend, Payable on October 1, 2025The Board of Directors of McKesson Corporation declared a regular dividend of $0.82 per share of common stock, a 15% increase from $0.71 per share in the prior quarter. The dividend will be payable on October 1, 2025, to stockholders of record on September 2, 2025.공고 • Jun 30+ 2 more updatesMcKesson Corporation(NYSE:MCK) dropped from Russell 1000 Growth-Defensive IndexMcKesson Corporation(NYSE:MCK) dropped from Russell 1000 Growth-Defensive Index공고 • Jun 26McKesson Corporation to Report Q1, 2026 Results on Aug 06, 2025McKesson Corporation announced that they will report Q1, 2026 results After-Market on Aug 06, 2025공고 • Jun 23McKesson Corporation, Annual General Meeting, Jul 30, 2025McKesson Corporation, Annual General Meeting, Jul 30, 2025.Upcoming Dividend • May 23Upcoming dividend of US$0.71 per shareEligible shareholders must have bought the stock before 30 May 2025. Payment date: 01 July 2025. Payout ratio is a comfortable 11% and this is well supported by cash flows. Trailing yield: 0.4%. Lower than top quartile of Italian dividend payers (5.5%). Lower than average of industry peers (2.3%).Reported Earnings • May 09Full year 2025 earnings released: EPS: US$25.86 (vs US$22.54 in FY 2024)Full year 2025 results: EPS: US$25.86 (up from US$22.54 in FY 2024). Revenue: US$359.1b (up 16% from FY 2024). Net income: US$3.30b (up 9.8% from FY 2024). Profit margin: 0.9% (down from 1.0% in FY 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 8.2% p.a. on average during the next 3 years, compared to a 4.9% growth forecast for the Healthcare industry in Europe.공고 • May 01McKesson Corporation Declares Quarterly Dividend, Payable on July 1, 2025The Board of Directors of McKesson Corporation declared a regular dividend of 71 cents per share of common stock. The dividend will be payable on July 1, 2025, to stockholders of record on June 2, 2025.매출 및 비용 세부 내역McKesson가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이BIT:1MCK 매출, 비용 및 순이익 (USD Millions)날짜매출순이익일반관리비연구개발비31 Mar 26403,4304,7628,239031 Dec 25397,9584,3408,362030 Sep 25387,0944,0337,331030 Jun 25377,5953,1648,118031 Mar 25359,0513,2957,998031 Dec 24344,5832,8268,031030 Sep 24330,1872,5368,755030 Jun 24313,7512,9598,113031 Mar 24308,9513,0028,010031 Dec 23301,5062,9987,809030 Sep 23291,0983,4877,972030 Jun 23284,0403,7557,881031 Mar 23276,7113,5637,914031 Dec 22273,9033,1468,258030 Sep 22272,0272,0618,438030 Jun 22268,4461,3968,702031 Mar 22263,9661,1198,937031 Dec 21257,0061,4158,918030 Sep 21250,991-4,8048,926030 Jun 21245,223-4,4948,919031 Mar 21238,228-4,5388,791031 Dec 20237,621-4,1898,696030 Sep 20234,1942,2288,875030 Jun 20231,0029228,864031 Mar 20231,0519068,907031 Dec 19224,945-9059,6417130 Sep 19221,981-6269,1607130 Jun 19217,4406018,6427131 Mar 19214,319338,437031 Dec 18213,518-3198,36212530 Sep 18210,9271138,19712530 Jun 18209,913-3848,30012531 Mar 18208,357628,13812531 Dec 17205,4424,8057,46434130 Sep 17201,9554,5397,50334130 Jun 17199,8514,8467,31734131 Mar 17198,5335,1947,44734131 Dec 16196,4982,0517,14939230 Sep 16194,2672,0447,26439230 Jun 16193,0712,3597,28339231 Mar 16190,8842,2907,37939231 Dec 15189,1312,2377,57339230 Sep 15187,7162,0907,342392양질의 수익: 1MCK는 고품질 수익을 보유하고 있습니다.이익 마진 증가: 1MCK의 현재 순 이익률 (1.2%)은 지난해 (0.9%)보다 높습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: 1MCK는 지난 5년 동안 흑자전환하며 연평균 44.3%의 수익 성장을 기록했습니다.성장 가속화: 지난 1년간 1MCK 의 수익 증가율(44.5%)은 연간 평균(44.3%)을 초과합니다.수익 대 산업: 1MCK의 지난 1년 수익 증가율(44.5%)은 Healthcare 업계의 3.5%를 상회했습니다.자기자본이익률높은 ROE: 1MCK의 부채가 자산을 초과하여 자본 수익률을 계산하기 어렵습니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YHealthcare 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/07/31 19:54종가2026/07/31 00:00수익2026/03/31연간 수익2026/03/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스McKesson Corporation는 32명의 분석가가 다루고 있습니다. 이 중 15명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관David ToungArgus Research CompanyEric ColdwellBairdLawrence MarshBarclays29명의 분석가 더 보기
공고 • Jun 25McKesson Corporation to Report Q1, 2027 Results on Aug 05, 2026McKesson Corporation announced that they will report Q1, 2027 results on Aug 05, 2026
Reported Earnings • May 08Full year 2026 earnings released: EPS: US$38.53 (vs US$25.86 in FY 2025)Full year 2026 results: EPS: US$38.53 (up from US$25.86 in FY 2025). Revenue: US$403.4b (up 12% from FY 2025). Net income: US$4.76b (up 45% from FY 2025). Profit margin: 1.2% (up from 0.9% in FY 2025). The increase in margin was driven by higher revenue. Revenue is forecast to grow 6.7% p.a. on average during the next 3 years, compared to a 5.1% growth forecast for the Healthcare industry in Europe.
공고 • Mar 06McKesson Corporation to Report Q4, 2026 Results on May 07, 2026McKesson Corporation announced that they will report Q4, 2026 results After-Market on May 07, 2026
Reported Earnings • Feb 05Third quarter 2026 earnings released: EPS: US$9.63 (vs US$6.98 in 3Q 2025)Third quarter 2026 results: EPS: US$9.63 (up from US$6.98 in 3Q 2025). Revenue: US$106.2b (up 11% from 3Q 2025). Net income: US$1.19b (up 35% from 3Q 2025). Profit margin: 1.1% (up from 0.9% in 3Q 2025). The increase in margin was driven by higher revenue. Revenue is forecast to grow 7.4% p.a. on average during the next 3 years, compared to a 5.2% growth forecast for the Healthcare industry in Europe.
공고 • Dec 22McKesson Corporation to Report Q3, 2026 Results on Feb 04, 2026McKesson Corporation announced that they will report Q3, 2026 results After-Market on Feb 04, 2026
Reported Earnings • Nov 06Second quarter 2026 earnings released: EPS: US$8.95 (vs US$1.87 in 2Q 2025)Second quarter 2026 results: EPS: US$8.95 (up from US$1.87 in 2Q 2025). Revenue: US$103.2b (up 10% from 2Q 2025). Net income: US$1.11b (up 361% from 2Q 2025). Profit margin: 1.1% (up from 0.3% in 2Q 2025). The increase in margin was driven by higher revenue. Revenue is forecast to grow 7.7% p.a. on average during the next 3 years, compared to a 5.1% growth forecast for the Healthcare industry in Europe.
공고 • Jul 23McKesson Corporation announces Quarterly dividend, payable on October 01, 2026McKesson Corporation announced Quarterly dividend of USD 0.9400 per share payable on October 01, 2026, ex-date on September 01, 2026 and record date on September 01, 2026.
공고 • Jul 01McKesson Corporation Announces Management Changes, Effective August 1, 2026McKesson Corporation announced that on June 29, 2026, Thomas L. Rodgers, the company's Executive Vice President, Chief Strategy and Business Development Officer and a named executive officer, gave notice of his intention to retire from that role. His last day of employment will be August 1, 2026. To support an orderly transition, the company appointed Ramesh Srinivasan as Executive Vice President, Chief Strategy Officer, effective on August 1, 2026.
공고 • Jun 25McKesson Corporation to Report Q1, 2027 Results on Aug 05, 2026McKesson Corporation announced that they will report Q1, 2027 results on Aug 05, 2026
공고 • Jun 15McKesson Corporation, Annual General Meeting, Jul 22, 2026McKesson Corporation, Annual General Meeting, Jul 22, 2026.
Upcoming Dividend • May 23Upcoming dividend of US$0.82 per shareEligible shareholders must have bought the stock before 29 May 2026. Payment date: 01 July 2026. Payout ratio is a comfortable 8.2% and this is well supported by cash flows. Trailing yield: 0.4%. Lower than top quartile of Italian dividend payers (4.5%). Lower than average of industry peers (2.6%).
Reported Earnings • May 08Full year 2026 earnings released: EPS: US$38.53 (vs US$25.86 in FY 2025)Full year 2026 results: EPS: US$38.53 (up from US$25.86 in FY 2025). Revenue: US$403.4b (up 12% from FY 2025). Net income: US$4.76b (up 45% from FY 2025). Profit margin: 1.2% (up from 0.9% in FY 2025). The increase in margin was driven by higher revenue. Revenue is forecast to grow 6.7% p.a. on average during the next 3 years, compared to a 5.1% growth forecast for the Healthcare industry in Europe.
Declared Dividend • May 04Dividend of US$0.82 announcedShareholders will receive a dividend of US$0.82. Ex-date: 29th May 2026 Payment date: 1st July 2026 Dividend yield will be 0.3%, which is lower than the industry average of 1.7%. Payout Ratios Payout ratio: 9%. Cash payout ratio: 4%.
공고 • Apr 23McKesson Corporation Declares Regular Dividend, Payable on July 1, 2026The Board of Directors of McKesson Corporation declared a regular dividend of 82 cents per share of common stock. The dividend will be payable on July 1, 2026, to shareholders of record on June 1, 2026.
공고 • Apr 22Apollo Global Management, Inc. (NYSE:APO) entered into a definitive agreement to acquire 13% stake in McKesson Medical-Surgical Inc. from McKesson Corporation (NYSE:MCK) for $1.3 billion.Apollo Global Management, Inc. (NYSE:APO) entered into a definitive agreement to acquire 13% stake in McKesson Medical-Surgical Inc. from McKesson Corporation (NYSE:MCK) for $1.3 billion on April 20, 2026. The consideration consists of convertible preferred equity of Apollo Global Management, Inc. having a value of $1.25 billion to be issued for common equity of McKesson Medical-Surgical Inc. Following the acquisition, McKesson will retain operating control and majority ownership of MMS and consolidate the results for financial reporting. The transaction is subject to regulatory approvals and customary closing conditions. Tracey Zaccone, Michael Anastasio, Salvatore Vanchieri, and Julian Azran of Latham & Watkins LLP acted as legal advisor for Apollo Global Management, Inc. Alan F. Denenberg and Michael Diz, Jason Bassetti, Patrick E. Sigmon, Liang Zhang, Adam Kaminsky, Frank Azzopardi, and Suzanne Munck af Rosenschold of Davis Polk & Wardwell LLP acted as legal advisor for McKesson Corporation.
New Risk • Mar 27New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Italian stocks, typically moving 7.6% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (7.6% average weekly change). Minor Risk Negative equity (-US$99m).
공고 • Mar 06McKesson Corporation to Report Q4, 2026 Results on May 07, 2026McKesson Corporation announced that they will report Q4, 2026 results After-Market on May 07, 2026
공고 • Mar 05+ 1 more updateMckesson Corporation Announces CFO TransitionMcKesson Corporation announced Britt Vitalone, Executive Vice President and Chief Financial Officer (CFO), has elected to retire after a successful and distinguished 20-year career with the company, including more than eight years as CFO. Looking ahead, Kenny Cheung will join McKesson as CFO, effective May 29, 2026. Vitalone’s care and commitment to McKesson continues. While he will retire as the CFO, he will continue his work with McKesson, thereafter, as a strategic advisor to support a smooth transition and the planned separation of McKesson’s Medical Surgical Solutions. Cheung joins McKesson from Sysco, where he served as Executive Vice President and Chief Financial Officer, overseeing global financial planning and analysis, accounting, audit, tax, and corporate finance.
Upcoming Dividend • Feb 20Upcoming dividend of US$0.82 per shareEligible shareholders must have bought the stock before 27 February 2026. Payment date: 01 April 2026. Payout ratio is a comfortable 8.8% and this is well supported by cash flows. Trailing yield: 0.4%. Lower than top quartile of Italian dividend payers (4.6%). Lower than average of industry peers (2.2%).
New Risk • Feb 10New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Italian stocks, typically moving 5.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Negative equity (-US$99m). Share price has been volatile over the past 3 months (5.2% average weekly change).
Reported Earnings • Feb 05Third quarter 2026 earnings released: EPS: US$9.63 (vs US$6.98 in 3Q 2025)Third quarter 2026 results: EPS: US$9.63 (up from US$6.98 in 3Q 2025). Revenue: US$106.2b (up 11% from 3Q 2025). Net income: US$1.19b (up 35% from 3Q 2025). Profit margin: 1.1% (up from 0.9% in 3Q 2025). The increase in margin was driven by higher revenue. Revenue is forecast to grow 7.4% p.a. on average during the next 3 years, compared to a 5.2% growth forecast for the Healthcare industry in Europe.
Declared Dividend • Feb 01Dividend of US$0.82 announcedShareholders will receive a dividend of US$0.82. Ex-date: 27th February 2026 Payment date: 1st April 2026 Dividend yield will be 0.3%, which is lower than the industry average of 1.7%. Payout Ratios Payout ratio: 9%. Cash payout ratio: 7%.
공고 • Jan 28Mckesson Corporation Declares Dividend, Payable on April 1, 2026McKesson Corporation declares regular dividend of 82 cents per share of common stock. The dividend will be payable on Aril 1, 2026 to shareholders of record on March 2, 2026.
공고 • Dec 22McKesson Corporation to Report Q3, 2026 Results on Feb 04, 2026McKesson Corporation announced that they will report Q3, 2026 results After-Market on Feb 04, 2026
Upcoming Dividend • Nov 21Upcoming dividend of US$0.82 per shareEligible shareholders must have bought the stock before 28 November 2025. Payment date: 02 January 2026. Payout ratio is a comfortable 9.1% and this is well supported by cash flows. Trailing yield: 0.4%. Lower than top quartile of Italian dividend payers (4.9%). Lower than average of industry peers (2.4%).
Reported Earnings • Nov 06Second quarter 2026 earnings released: EPS: US$8.95 (vs US$1.87 in 2Q 2025)Second quarter 2026 results: EPS: US$8.95 (up from US$1.87 in 2Q 2025). Revenue: US$103.2b (up 10% from 2Q 2025). Net income: US$1.11b (up 361% from 2Q 2025). Profit margin: 1.1% (up from 0.3% in 2Q 2025). The increase in margin was driven by higher revenue. Revenue is forecast to grow 7.7% p.a. on average during the next 3 years, compared to a 5.1% growth forecast for the Healthcare industry in Europe.
Declared Dividend • Nov 03Dividend of US$0.82 announcedShareholders will receive a dividend of US$0.82. Ex-date: 28th November 2025 Payment date: 2nd January 2026 Dividend yield will be 0.3%, which is lower than the industry average of 1.7%. Payout Ratios Payout ratio: 11%. Cash payout ratio: 7%.
공고 • Oct 30McKesson Corporation Declares Quarterly Dividend on Common Stock, Payable on January 2, 2026The Board of Directors of McKesson Corporation declared a regular dividend of 82 cents per share of common stock. The dividend will be payable on January 2, 2026 to shareholders of record on December 1, 2025.
공고 • Sep 23McKesson Corporation to Report Q2, 2026 Results on Nov 05, 2025McKesson Corporation announced that they will report Q2, 2026 results at 4:00 PM, US Eastern Standard Time on Nov 05, 2025
Reported Earnings • Aug 07First quarter 2026 earnings released: EPS: US$6.28 (vs US$7.05 in 1Q 2025)First quarter 2026 results: EPS: US$6.28 (down from US$7.05 in 1Q 2025). Revenue: US$97.8b (up 23% from 1Q 2025). Net income: US$784.0m (down 14% from 1Q 2025). Profit margin: 0.8% (down from 1.2% in 1Q 2025). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 7.5% p.a. on average during the next 3 years, compared to a 5.0% growth forecast for the Healthcare industry in Europe.
공고 • Jul 30Mckesson Corporation Declares Regular Dividend, Payable on October 1, 2025The Board of Directors of McKesson Corporation declared a regular dividend of $0.82 per share of common stock, a 15% increase from $0.71 per share in the prior quarter. The dividend will be payable on October 1, 2025, to stockholders of record on September 2, 2025.
공고 • Jun 30+ 2 more updatesMcKesson Corporation(NYSE:MCK) dropped from Russell 1000 Growth-Defensive IndexMcKesson Corporation(NYSE:MCK) dropped from Russell 1000 Growth-Defensive Index
공고 • Jun 26McKesson Corporation to Report Q1, 2026 Results on Aug 06, 2025McKesson Corporation announced that they will report Q1, 2026 results After-Market on Aug 06, 2025
공고 • Jun 23McKesson Corporation, Annual General Meeting, Jul 30, 2025McKesson Corporation, Annual General Meeting, Jul 30, 2025.
Upcoming Dividend • May 23Upcoming dividend of US$0.71 per shareEligible shareholders must have bought the stock before 30 May 2025. Payment date: 01 July 2025. Payout ratio is a comfortable 11% and this is well supported by cash flows. Trailing yield: 0.4%. Lower than top quartile of Italian dividend payers (5.5%). Lower than average of industry peers (2.3%).
Reported Earnings • May 09Full year 2025 earnings released: EPS: US$25.86 (vs US$22.54 in FY 2024)Full year 2025 results: EPS: US$25.86 (up from US$22.54 in FY 2024). Revenue: US$359.1b (up 16% from FY 2024). Net income: US$3.30b (up 9.8% from FY 2024). Profit margin: 0.9% (down from 1.0% in FY 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 8.2% p.a. on average during the next 3 years, compared to a 4.9% growth forecast for the Healthcare industry in Europe.
공고 • May 01McKesson Corporation Declares Quarterly Dividend, Payable on July 1, 2025The Board of Directors of McKesson Corporation declared a regular dividend of 71 cents per share of common stock. The dividend will be payable on July 1, 2025, to stockholders of record on June 2, 2025.